(Q36505723)

14 August 2017

1 reference

title

Role of alloantibodies in the pathogenesis of graft arteriosclerosis in cardiac transplantation (English)

1 reference

14 August 2017

Soleimani B

1

1 reference

14 August 2017

Lechler RI

series ordinal

2

1 reference

14 August 2017

Hornick PI

series ordinal

3

1 reference

14 August 2017

George AJ

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

12 June 2006

1 reference

American Journal of Transplantation

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

8

1 reference

14 August 2017

1781-1785

1 reference

Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Activation of autoimmune B cells and chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Anti-HLA antibodies in heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Signal transduction via MHC class I molecules in endothelial and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

C4d deposition in cardiac allografts correlates with alloantibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Immunologic basis of transplant-associated arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Role of the antibody in the pathogenesis of transplant vascular sclerosis: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

The role of t/b lymphocyte collaboration in the regulation of autoimmune and alloimmune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

Morphologic observations in the epicardial coronary arteries and their surroundings late after cardiac transplantation (allograft vascular disease)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01401.X

10.1111/J.1600-6143.2006.01401.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference